Country: Australia
Bahasa: Inggeris
Sumber: APVMA (Australian Pesticides and Veterinary Medicines Authority)
CANINE DISTEMPER VIRUS - LIVING; CANINE PARAINFLUENZA VIRUS; CANINE ADENOVIRUS TYPE 2 LIVE (CAV II); CANINE PARVO VIRUS
INTERVET AUSTRALIA PTY LIMITED
canine distemper virus(1000U/dose)+canine adenovirus(10000U/dose) + others
MISC. VACCINES OR ANTI SERA
CANINE DISTEMPER VIRUS - LIVING VACCINE-VIRAL Active 0.0 Undefined; CANINE PARAINFLUENZA VIRUS VACCINE-VIRAL Active 0.0 Undefined; CANINE ADENOVIRUS TYPE 2 LIVE (CAV II) VACCINE-VIRAL Active 0.0 Undefined; CANINE PARVO VIRUS VACCINE-VIRAL Active 0.0 Undefined
10 x 1mL; 20 x 1mL; 25 x 1mL; 50 x 1mL; Vial = 1mL
VM - Veterinary Medicine
INTERVET AUSTRALIA
DOG | BITCH | CASTRATE | PUPPY
IMMUNOTHERAPY
CANINE ADENOVIRUS - TYPE 2 | CANINE DISTEMPER | CANINE PARAINFLUENZA | CANINE PARVOVIRUS | VACCINE | EQUINE ROTAVIRUS | PARVOVIRUS
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [CANINE ADENOVIRUS - TYPE 2, CANINE DISTEMPER, CANINE PARAINFLUENZA, CANINE PARVOVIRUS, VACCINE]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [CANINE ADENOVIRUS - TYPE 2, CANINE DISTEMPER, CANINE PARAINFLUENZA, CANINE PARVOVIRUS, VACCINE]; For vaccination against distemper, contagious hepatitis, parvovirus, and parainfluenza infections in dogs.AVOID USING in dogs receiving corticosteroids or in pregnant bitches.
Registered
2023-07-01
For Official Use Only E-LABEL APPLICATION (DRAFT) COMPANY NAME: INTERVET AUSTRALIA PTY LIMITED PRODUCT NAME: COMPANION C4 QUADRIVALENT LIVING VACCINE FOR DOGS ELABEL APPLICATION NO: DC12-21362273E8 APVMA APPROVAL NO: 56438/ 100864 PRODUCT NO: 56438 VERSION NO: 5.0 APPLICATION STARTED: 2014-Oct-31 15:44:06 VERSION CREATED: 2015-Feb-27 15:26:00 STARTED BY: Lyn Lavidis PRINTED: 2015-Feb-27 15:42:22 LABEL NAME: COMPANION C4 QUADRIVALENT LIVING VACCINE FOR DOGS SIGNAL HEADINGS: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY CONSTITUENT STATEMENTS: ACTIVE CONSTITUENTS: Each single dose vial contains (minimum titres in TCID50): -live, attenuated canine distemper virus ……………………………..10^3 -live, attenuated canine adenovirus type 2 (infectious hepatitis) ... 10^4 -live, attenuated canine parvovirus …………………………………..10^5 -live, attenuated canine parainfluenza virus………………………....10^5 CLAIMS: For vaccination against distemper, infectious hepatitis, parvovirus and parainfluenza infections in dogs. NET CONTENTS: 1 dose (1 mL after reconstitution) 10 x single dose vials 20 x single dose vials 25 x single dose vials 50 x single dose vials DIRECTIONS FOR USE: DIRECTIONS FOR USE: Only healthy dogs possessing normal temperatures should be vaccinated. AVOID USING chemicals to disinfect the skin, needles or syringes before vaccination as this could inactivate the viruses. CONTRAINDICATIONS: CONTRAINDICATIONS: This product should not be used in dogs receiving corticosteroids or in pregnant bitches. RLP APPROVED For Official Use Only DOSAGE AND ADMINISTRATION: DOSAGE AND ADMINISTRATION Use Immediately after reconstitution with 1mL of a suitable diluent (i.e water for Injections BP) transferred aseptically. Note: The removable label should only be removed after the dose has been given. Under Normal circumstances: Primary vaccination in puppies from 8 weeks of age: inject subcutaneously or intramuscularly 2 doses of vaccine at an interval of Baca dokumen lengkap
PRODUCT NAME: COMPANION™ C4 QUADRIVALENT LIVING VACCINE FOR DOGS MATERIAL SAFETY DATA SHEET THIS REVISION ISSUED: JULY, 2009 PAGE: 1 OF 5 MATERIAL SAFETY DATA SHEET Issued by: Intervet Australia Pty Limited Phone: 1 800 033 461 (Business Hours) Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800 764 766 in New Zealand) SUBSTANCE: Solid plug is freeze dried live virus. Liquid is saline for reconstitution. TRADE NAME: COMPANION™ C4 QUADRIVALENT LIVING VACCINE FOR DOGS PRODUCT CODE: 3973 RECOMMENDED USE: For the active immunisation of dogs against canine distemper, contagious hepatitis, canine parvovirus and canine parainfluenza type II viruses. APVMA NO: 56438 CREATION DATE: November, 2006 THIS VERSION ISSUED: July, 2009 and is valid for 5 years from this date. STATEMENT OF HAZARDOUS NATURE: THIS PRODUCT IS CLASSIFIED AS: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S22. Do not breathe dust. SUSDP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated PHYSICAL DESCRIPTION & COLOUR: Pale yellow freeze dried powder for reconstitution. ODOUR: No odour. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. INHALATION: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. LONG TERM EXPOSURE: No data for health effects associated with long term inhalation. SKIN CONTACT: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. It should present no hazards in normal use. In addition product is unlikely to cause any discomfort in normal use. LONG TERM EXPOSURE: No data for health effects associated with long term skin exposure. EYE CONTACT: SHORT TERM EXPOSURE : This product may be mildly irritating to eyes, but is unlikely to cause Baca dokumen lengkap